Rainbow Childrens Medicare share price today

Rainbow Childrens Medicare Ltd's share price was ₹1,279.60 at the close on 4 November 2026. It has been falling for 1 week. That is 5.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,114 and ₹1,557, and at that close it sat 37% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Rainbow Childrens Medicare Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 7 weeks running.

Over the last 4.5 years the share price moved +180% while the NIFTY 500 moved +57%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: foreign funds (FIIs) cut their stake for 7 quarters in a row, indian funds and insurers (DIIs) raised their stake for 9 quarters in a row and revenue up on a year earlier for 12 quarters in a row (every quarter we can compare).

1. Foreign funds (FIIs) cut their stake for 7 quarters in a row

   From 25.1% to 14.7% of the company by the September 2026 quarter.

2. Indian funds and insurers (DIIs) raised their stake for 9 quarters in a row

   From 13.8% to 23.3% of the company by the September 2026 quarter.

3. Revenue up on a year earlier for 12 quarters in a row (every quarter we can compare)

   In the September 2026 quarter revenue was ₹548 crore, +23.1% on a year earlier.

For July to September 2026 (the quarter ended 30 September 2026), Rainbow Childrens Medicare reported revenue of ₹548 crore, up 23.1% from ₹445 crore a year earlier, and a profit of ₹84.0 crore, up 10.5% from ₹76.0 crore.

Rainbow Childrens Medicare results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 31 July 2026, about April to June 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Rainbow Childrens Medicare closed at ₹1,279.60 on 4 November 2026, down 6.8% from ₹1,373.50 a year earlier (7 November 2025) and up 23.3% over three years. Its highest weekly close since May 2022 was ₹1,649.75 on 14 November 2024.

Rainbow Childrens Medicare share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

241 weekly closes from 13 May 2022 to 4 November 2026.

4 Nov 2026: Rainbow Childrens Medicare closed at ₹1,279.60, up 5.0% on the week and up 0.0% on the month. Results for July to September 2026: Revenue up 23.1% and profit up 10.5% on a year earlier.

Earlier

• 31 Jul 2026: Rainbow Childrens Medicare held its results call for April to June 2026. Management guided: Add 2,500 beds over 5 years to reach 5,000 network beds, with estimated capital spending around ₹2,200 crore; 1,200 beds are already in execution.
• 21 Jul 2026: ex-date for a dividend of ₹3.50 a share.

Rainbow Childrens Medicare paid ₹3.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.27% at the ₹1,279.60 close on 4 November 2026. The last was a dividend of ₹3.50 a share, ex-date 21 July 2026.

Rainbow Childrens Medicare dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Rainbow Childrens Medicare Ltd paid out 13% of its profit as dividends in FY26, and it paid a dividend in 12 of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 31 July 2026, Rainbow Childrens Medicare's management guided: Add 2,500 beds over 5 years to reach 5,000 network beds, with estimated capital spending around ₹2,200 crore; 1,200 beds are already in execution.

“Over the next 5 years, we plan to add 2,500 beds to expand our network capacity to 5,000 beds through estimated capex of around Rs 2,200 crore.”Dr. Ramesh Kancharla, on the call for April to June 2026

What management guided

• Commissioning schedule: Indore in October to December 2026; Coimbatore and Gurgaon Sector 56 in October to December 2027; Gurgaon Sector 44 in April to June 2028; Pune 150-bed and Bengaluru Sarjapur facilities in FY29.
• Malad's 100-bed brownfield hospital is expected to commence in April to June 2027; Nellore's 30-bed maternal block is expected within 6 months and Guntur's 50-bed facility in a couple of months.
• Incremental beds are expected to be allocated approximately 30.0% to southern markets and 70.0% to new markets, including NCR, Central India and Mumbai.
• July to September 2026 revenue growth is expected around 20.0%, with management stating it should not be less than 20.0%; the medium-term goal is 20.0% growth, implying revenue doubles in 4 years.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 31 July 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When Rainbow Childrens Medicare reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: July to September 2026 reported revenue growth to remain at least approximately 20.0%, consistent with management's extracted commitment.

Rainbow Childrens Medicare is not on any of our India lists this week.

Rainbow Childrens Medicare Ltd earned ₹84.0 Cr of net profit in the Sep 2026 quarter, +10.5% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY26 profit was ₹282 Cr. Over 10 years profit has grown 32.4% a year on average. That is 15.3% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹76.0 Cr.

For the full year, FY26 profit was ₹282 Cr (+15.6% on the year before).

Why profit moved: revenue changed +23.1% on a year earlier and the margin moved −2.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +17.8% and revenue +23.1%. Profit is growing slower than sales: rising costs are taking part of the growth.

Rainbow Childrens Medicare Ltd reported ₹548 Cr of revenue in the Sep 2026 quarter, +23.1% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 22.0% a year on average. The last full year, FY26, came in at ₹1,703 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹1,923 Cr.

FY26 revenue was ₹1,703 Cr, +12.3% on the year before.

Recent pace: the last four quarters grew +23.1% on average, against 22.0% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +22.8%, against +16.2% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +16.8%, against +13.3% a year (accelerating).

Rainbow Childrens Medicare Ltd's operating margin was 31.0% in the Sep 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 13.0% and 34.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −2.4 percentage points on the year while gross margin changed +0.5 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 153% of Rainbow Childrens Medicare Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹420 Cr of operating cash against ₹282 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹560 Cr of spending on assets, free cash was −₹140 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 153% of profit came in as cash: the cash cycle got 57 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 3.2× depreciation over three years. The next section checks what that spending is building.

Rainbow Childrens Medicare Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −73 days in FY26, up from −130 days in FY21. It spent ₹1,282 Cr on assets over the last 3 years. Customers take 22 days to pay, and stock sits for 67 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹1,703 Cr, each day of that cycle ties up about ₹4.7 Cr, so roughly −₹341 Cr is tied up in the business at any time.

FY26: customers took 22 days to pay and stock sat for 67 days, about 2.2 months of sales sitting as stock, for a full cycle of −73 days, longer than FY21's −130.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 67 days. Customers pay about 22 days after that. Suppliers are paid at 162 days. Together that makes the −73-day cycle.

Spending on assets: ₹1,282 Cr over the last 3 years, against ₹401 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹79.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Rainbow Childrens Medicare Ltd's P/E is 44.3×, near the low end of its own history: it has been lower only 4% of the time. Its usual P/E (the middle reading) is 53.5×, over 4.5 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved +14.3% while the price moved −6.8%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved +7.2% a year; about +10.3% a year came from earnings growth and about −3.1 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Rainbow Childrens Medicare Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 18.7%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: steady growth with healthy returns is how a business compounds over time.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Rainbow Childrens Medicare Ltd earned a ROCE of 17% in FY26. That is up from a low of 11% in FY16. Its return on capital used (ROIC) is 3.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 16.6% net margin and 0.61× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 16.6% net margin × 0.61× asset turnover × 1.68× leverage (assets divided by equity) ≈ 17.0% on equity. The margin does most of the work; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 15.1% − 12.0% = +3.1 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

The 15.1% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 17.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Rainbow Childrens Medicare Ltd has total debt of ₹891 Cr against shareholder equity of ₹1,664 Cr as of Jun 2026, so its debt is 0.54× its equity. Year by year, that ratio went from 0.96 in FY22 to 0.54 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Foreign institutions cut their stake in Rainbow Childrens Medicare Ltd by 10.5 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 14.7% of the company. Domestic institutions moved +9.4 points over the same period, to 23.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −10.5 points over 8 quarters, to 14.7%; Domestic institutions: +9.4 points over 8 quarters, to 23.3%; Promoters: +0.0 points over 8 quarters, to 49.8%.

Why the owners changed: foreign institutions moved −10.5 points and domestic institutions +9.4 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company.

For Rainbow Childrens Medicare Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

50.1 out of 100, rank 11 of 20 in Hospitals, with 100% of the evidence available.

Rainbow Childrens Medicare Ltd scores 50.1 out of 100 against the 20 companies it is compared with in Hospitals, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 17.5 + 19.9 + 9.3 + 3.4 = 50.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Rainbow Childrens Medicare ranks 11 of 20 Hospitals companies on the 4-Factor Sector Score, with 50.1 out of 100.